TY - JOUR AU - Kantor, A. F. PY - 1976 DA - 1976// TI - Upton Sinclair and the Pure Food and Drugs Act of 1906: ‘I aimed at the public’s heart and by accident I hit it in the stomach JO - Am J Public Health VL - 66 UR - https://doi.org/10.2105/AJPH.66.12.1202 DO - 10.2105/AJPH.66.12.1202 ID - Kantor1976 ER - TY - JOUR AU - Jacobson, P. D. AU - Parmet, W. E. PY - 2007 DA - 2007// TI - A new era of unapproved drugs: the case of Abigail Alliance v Von Eschenbach JO - JAMA VL - 297 UR - https://doi.org/10.1001/jama.297.2.205 DO - 10.1001/jama.297.2.205 ID - Jacobson2007 ER - TY - JOUR AU - Mackey, T. K. AU - Schoenfeld, V. J. PY - 2016 DA - 2016// TI - Getting ‘social’ to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access JO - BMC Med VL - 14 UR - https://doi.org/10.1186/s12916-016-0568-8 DO - 10.1186/s12916-016-0568-8 ID - Mackey2016 ER - TY - STD TI - https://www.abigail-alliance.org/story.php. Accessed 5 Dec 2019. UR - https://www.abigail-alliance.org/story.php ID - ref4 ER - TY - JOUR AU - Own, D. PY - 2018 DA - 2018// TI - Trump signs bill to give patients right to try drugs JO - BMJ VL - 361 ID - Own2018 ER - TY - JOUR AU - Piel, J. PY - 2016 DA - 2016// TI - Informed consent in right-to-try cases JO - J Am Acad Psychiatry Law VL - 44 ID - Piel2016 ER - TY - JOUR AU - DiMasi, J. A. AU - Grabowskib, H. G. AU - Hansenc, R. W. PY - 2016 DA - 2016// TI - Innovation in the pharmaceutical industry: new estimates of R&D costs JO - J Health Econ VL - 47 UR - https://doi.org/10.1016/j.jhealeco.2016.01.012 DO - 10.1016/j.jhealeco.2016.01.012 ID - DiMasi2016 ER - TY - STD TI - Mestre-Ferrandiz J, Sussex J, Towse A. The R&D cost of new medicine. 2012. https://www.ohe.org/publications/rd-cost-new-medicine. Accessed 7 Feb 2020. UR - https://www.ohe.org/publications/rd-cost-new-medicine ID - ref8 ER - TY - JOUR AU - Tysome, J. R. AU - Lemoine, N. R. AU - Wang, Y. PY - 2013 DA - 2013// TI - Update on oncolytic viral therapy—targeting angiogenesis JO - Onco Targets Ther VL - 6 UR - https://doi.org/10.2147/OTT.S46974 DO - 10.2147/OTT.S46974 ID - Tysome2013 ER - TY - JOUR AU - Jia, H. AU - Kling, J. PY - 2006 DA - 2006// TI - China offers alternative gateway for experimental drugs JO - Nat Biotechnol VL - 24 UR - https://doi.org/10.1038/nbt0206-117 DO - 10.1038/nbt0206-117 ID - Jia2006 ER - TY - JOUR AU - Zhang, W. AU - Li, L. AU - Li, D. AU - Liu, J. AU - Li, X. AU - Li, W. AU - Xu, X. AU - Zhang, M. J. AU - Chandler, L. A. AU - Lin, H. AU - Hu, A. AU - Xu, W. AU - Lam, D. M. PY - 2018 DA - 2018// TI - The first approved gene therapy product for cancer Ad-p53 (gendicine): 12 years in the clinic JO - Hum Gene Ther. VL - 29 UR - https://doi.org/10.1089/hum.2017.218 DO - 10.1089/hum.2017.218 ID - Zhang2018 ER - TY - STD TI - China’s New Drug Administration Law frames a promising regulatory landscape. 2019; 23:12. https://www.asiabiotech.com/23/2312/23120020x.html. UR - https://www.asiabiotech.com/23/2312/23120020x.html ID - ref12 ER - TY - STD TI - https://www.gilead.com/purpose/advancing-global-health/covid-19. Accessed 13 May 2020. UR - https://www.gilead.com/purpose/advancing-global-health/covid-19 ID - ref13 ER - TY - JOUR AU - Horstmann, E. AU - McCabe, M. AU - Grochow, L. AU - Yamamoto, S. AU - Rubinstein, L. AU - Budd, T. AU - Shoemaker, D. AU - Emanuel, E. AU - Grady, C. PY - 2005 DA - 2005// TI - Risks and benefits of phase 1 oncology trials, 1991 through 2002 JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMsa042220 DO - 10.1056/NEJMsa042220 ID - Horstmann2005 ER - TY - STD TI - https://clinicaltrials.gov/ct2/results?recrs=ab&cond=Lung+Cancer&term=&cntry=US&state=&city=&dist=. Accessed 7 Feb 2020. UR - https://clinicaltrials.gov/ct2/results%3frecrs%3dab%26cond%3dLung%2bCancer%26term%3d%26cntry%3dUS%26state%3d%26city%3d%26dist%3d ID - ref15 ER - TY - JOUR AU - Boussadi, A. AU - Caruba, T. AU - Zapletal, E. AU - Sabatie, B. R. AU - Durieux, P. AU - Patrice, D. e. g. o. u. l. e. t. P. PY - 2012 DA - 2012// TI - A clinical data warehouse-based process for refining medication orders alerts JO - J Am Med Inform Assoc VL - 19 UR - https://doi.org/10.1136/amiajnl-2012-000850 DO - 10.1136/amiajnl-2012-000850 ID - Boussadi2012 ER - TY - STD TI - Using Watson Studio and Knowledge Catalog, Data Refinery saves data preparation time by quickly transforming large amounts of raw data into consumable quality information. https://www.ibm.com/cloud/data-refinery?p1=Search&p4=p50367843279&p5=b&p1=Search&p4=p50367843279&p5=b&p1=Search&p4=p50367843279&p5=b&cm_mmc=Search_Bing-_-1S_1S-_-WW_NA-_-%2Bdata%20%2Brefinery_b&cm_mmca7=71700000060884993&cm_mmca8=kwd-81226564052940:aud-807596473:loc-71283&cm_mmca9=CKT45PeiqOgCFQKrxQIdMe0EFA&cm_mmca10=81226482883052&cm_mmca11=b&&utm_source=bing&utm_medium=cpc&utm_campaign=Search%7CAI%7CLower%7CWW%7CNA%7CGeneric%7CEN%7CBMM&utm_term=%2Bdata%20%2Brefinery&utm_content=Data%20Refinery_Data%20Refinery_Generic_BMM_NULL&gclid=CKT45PeiqOgCFQKrxQIdMe0EFA&gclsrc=ds. UR - https://www.ibm.com/cloud/data-refinery%3fp1%3dSearch%26p4%3dp50367843279%26p5%3db%26p1%3dSearch%26p4%3dp50367843279%26p5%3db%26p1%3dSearch%26p4%3dp50367843279%26p5%3db%26cm_mmc%3dSearch_Bing-_-1S_1S-_-WW_NA-_-%252Bdata%20%252Brefinery_b%26cm_mmca7%3d71700000060884993%26cm_mmca8%3dkwd-81226564052940:aud-807596473:loc-71283%26cm_mmca9%3dCKT45PeiqOgCFQKrxQIdMe0EFA%26cm_mmca10%3d81226482883052%26cm_mmca11%3db%26%26utm_source%3dbing%26utm_medium%3dcpc%26utm_campaign%3dSearch%257CAI%257CLower%257CWW%257CNA%257CGeneric%257CEN%257CBMM%26utm_term%3d%252Bdata%20%252Brefinery%26utm_content%3dData%20Refinery_Data%20Refinery_Generic_BMM_NULL%26gclid%3dCKT45PeiqOgCFQKrxQIdMe0EFA%26gclsrc%3dds ID - ref17 ER - TY - JOUR AU - Sandhu, C. AU - Qureshi, A. AU - Emili, E. PY - 2018 DA - 2018// TI - Panomics for precision medicine JO - Trends Mol Med VL - 24 UR - https://doi.org/10.1016/j.molmed.2017.11.001 DO - 10.1016/j.molmed.2017.11.001 ID - Sandhu2018 ER - TY - JOUR AU - Hasin, Y. AU - Seldin, M. AU - Lusis, A. PY - 2017 DA - 2017// TI - Multi-omics approaches to disease JO - Genome Biol VL - 18 UR - https://doi.org/10.1186/s13059-017-1215-1 DO - 10.1186/s13059-017-1215-1 ID - Hasin2017 ER - TY - JOUR AU - Yi, M. AU - Yu, S. AU - Qin, S. AU - Liu, Q. AU - Xu, H. AU - Zhao, W. AU - Chu, Q. AU - Wu, K. PY - 2018 DA - 2018// TI - Gut microbiome modulates efficacy of immune checkpoint inhibitors JO - J Hematol Oncol VL - 11 UR - https://doi.org/10.1186/s13045-018-0592-6 DO - 10.1186/s13045-018-0592-6 ID - Yi2018 ER - TY - JOUR AU - Gopalakrishnan, V. AU - Helmink, B. A. AU - Spencer, C. N. AU - Reuben, A. AU - Wargo, J. A. PY - 2018 DA - 2018// TI - The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy JO - Cancer Cell VL - 33 UR - https://doi.org/10.1016/j.ccell.2018.03.015 DO - 10.1016/j.ccell.2018.03.015 ID - Gopalakrishnan2018 ER - TY - STD TI - Moor K, Heukels P, Kool M, Wijsenbeek M. Integrating patient perspectives into personalized medicine in idiopathic pulmonary fibrosis. https://www.researchgate.net/publication/321945065. Accessed 9 Jan 2020. UR - https://www.researchgate.net/publication/321945065 ID - ref22 ER - TY - STD TI - American College of Physicians. “Sir William osler and internal medicine”. https://www.acponline.org/about-acp/about-internal-medicine/sir-william-osler-and-internal-medicine. Accessed 11 Jan 2020. UR - https://www.acponline.org/about-acp/about-internal-medicine/sir-william-osler-and-internal-medicine ID - ref23 ER - TY - JOUR AU - Rothstein, M. A. PY - 2016 DA - 2016// TI - Some lingering concerns about the precision medicine initiative: currents in contemporary bioethics JO - J Law Med Ethics VL - 44 UR - https://doi.org/10.1177/1073110516667948 DO - 10.1177/1073110516667948 ID - Rothstein2016 ER - TY - STD TI - Real-world evidence. FDA. http://www.fda.gov. Accessed 24 Mar 2020. UR - http://www.fda.gov ID - ref25 ER - TY - STD TI - 21st Centuary Cures Act. https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/21st-century-cures-act. Accessed 3 Feb 2020. UR - https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/21st-century-cures-act ID - ref26 ER - TY - STD TI - Updated data from phase 3 trial of Ibrance (palbocicilib) plus letrozole in ER+, HER2− metastatic breast cancer confirm improvement in progression-free survival. https://www.pfizer.com/news/press-release/press-release-detail/updated_data_from_phase_3_trial_of_ibrance_palbociclib_plus_letrozole_in_er_her2_metastatic_breast_cancer_confirm_improvement_in_progression_free_survival. Accessed 8 Mar 2020. UR - https://www.pfizer.com/news/press-release/press-release-detail/updated_data_from_phase_3_trial_of_ibrance_palbociclib_plus_letrozole_in_er_her2_metastatic_breast_cancer_confirm_improvement_in_progression_free_survival ID - ref27 ER - TY - JOUR AU - Taylor-Stokes, G. AU - Mitra, D. AU - Waller, J. AU - Gibson, K. AU - Milligan, G. AU - Iyer, S. PY - 2019 DA - 2019// TI - Treatment patterns and clinical outcomes among patients receiving palbociclib in combination with an aromatase inhibitor or fulvestrant for HR+/HER2-negative advanced/metastatic breast cancer in real-world settings in the US: results from the IRIS study JO - Breast VL - 43 UR - https://doi.org/10.1016/j.breast.2018.10.009 DO - 10.1016/j.breast.2018.10.009 ID - Taylor-Stokes2019 ER - TY - STD TI - Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new strategic framework to advance use of real-world evidence to support development of drugs and biologics. https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-fdas-new-strategic-framework-advance-use-real-world. Accessed 8 Mar 2020. UR - https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-fdas-new-strategic-framework-advance-use-real-world ID - ref29 ER - TY - STD TI - Implementing Genomics in Practice. https://gmkb.org/. Accessed 2 Mar 2020. UR - https://gmkb.org/ ID - ref30 ER - TY - STD TI - David Raths. IBM Watson Teams with Vanderbilt, Brigham and women’s. Applying AI to improve utility EHR, claims data to address public health issues. 2019. https://www.hcinnovationgroup.com/analytics-ai/artifical-intelligence-machine-learning/news/21068437/ibm-watson-teams-with-vanderbilt-brigham-and-womens. Accessed 22 Feb 2020. UR - https://www.hcinnovationgroup.com/analytics-ai/artifical-intelligence-machine-learning/news/21068437/ibm-watson-teams-with-vanderbilt-brigham-and-womens ID - ref31 ER - TY - JOUR AU - McConnell, P. AU - Dash, R. C. AU - Chilukuri, R. AU - Pietrobon, R. AU - Johnson, K. AU - Annechianrico, R. AU - Cuticchia, J. A. PY - 2008 DA - 2008// TI - The cancer translational research informatics platform JO - BMC Med Inform Decis Mak VL - 8 UR - https://doi.org/10.1186/1472-6947-8-60 DO - 10.1186/1472-6947-8-60 ID - McConnell2008 ER - TY - STD TI - https://www.ecmcnetwork.org.uk/. Accessed 4 Jan 2020. UR - https://www.ecmcnetwork.org.uk/ ID - ref33 ER - TY - STD TI - Jessica Kent. NIH precision medicine trial releases cancer study. 2019. https://healthitanalytics.com/news/nih-precision-medicine-trial-releases-cancer-study-results. Accessed 18 Jan 2020. UR - https://healthitanalytics.com/news/nih-precision-medicine-trial-releases-cancer-study-results ID - ref34 ER - TY - STD TI - Pan-cancer analysis of whole genomes. Nature. 2020;578:82–93. https://doi.org/10.1038/s41586-020-1969-6. ID - ref35 ER -